These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2869845)

  • 1. Interaction between growth hormone releasing factor (GRF) and somatostatin analogue (SMS 201-995) in normal subjects.
    Losa M; Müller OA; Sobieszczyk S; von Werder K
    Clin Endocrinol (Oxf); 1985 Dec; 23(6):715-20. PubMed ID: 2869845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment with somatostatin analog SMS 201-995 potentiates growth hormone (GH) responsiveness to GH-releasing factor in short children.
    Dickerman Z; Guyda H; Tannenbaum GS
    J Clin Endocrinol Metab; 1993 Sep; 77(3):652-7. PubMed ID: 8257527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central effects of growth hormone-releasing hexapeptide (GHRP-6) on growth hormone release are inhibited by central somatostatin action.
    Fairhall KM; Mynett A; Robinson IC
    J Endocrinol; 1995 Mar; 144(3):555-60. PubMed ID: 7738479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.
    Lanzi R; Tannenbaum GS
    Endocrinology; 1992 Apr; 130(4):1822-8. PubMed ID: 1347739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of active immunization against somatostatin on serum growth hormone concentration in growing pigs: influence of fasting and repetitive somatocrinin injections.
    Dubreuil P; Pelletier G; Petitclerc D; Lapierre H; Gaudreau P; Brazeau P
    Endocrinology; 1989 Sep; 125(3):1378-84. PubMed ID: 2569391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone ontogeny in the ovine fetus and neonate. XXII. The effect of somatostatin on the growth hormone (GH) response to GH-releasing factor.
    de Zegher F; Daaboul J; Grumbach MM; Kaplan SL
    Endocrinology; 1989 Mar; 124(3):1114-7. PubMed ID: 2563681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects.
    Losa M; Bock L; Schopohl J; Stalla GK; Müller OA; von Werder K
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):462-70. PubMed ID: 6440392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion.
    Turner JP; Tannenbaum GS
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E683-90. PubMed ID: 7485482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of pituitary size by the somatostatin analogue SMS 201-995 in a patient with an islet cell tumour secreting growth hormone releasing factor.
    Wilson DM; Hoffman AR
    Acta Endocrinol (Copenh); 1986 Sep; 113(1):23-8. PubMed ID: 2876570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) secretion in the dwarf rat: release, clearance and responsiveness to GH-releasing factor and somatostatin.
    Carmignac DF; Robinson IC
    J Endocrinol; 1990 Oct; 127(1):69-75. PubMed ID: 1983310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of restricted feeding on the relationship between hypophysial portal concentrations of growth hormone (GH)-releasing factor and somatostatin, and jugular concentrations of GH in ovariectomized ewes.
    Thomas GB; Cummins JT; Francis H; Sudbury AW; McCloud PI; Clarke IJ
    Endocrinology; 1991 Feb; 128(2):1151-8. PubMed ID: 1671214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H; Arimura A; Frohman LA
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine regulation of growth hormone secretion in sheep. V. Growth hormone releasing factor and thyrotrophin releasing hormone.
    Spencer GS; Aitken WM; Hodgkinson SC; Bass JJ
    Domest Anim Endocrinol; 1992 Apr; 9(2):115-23. PubMed ID: 1617957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The episodic secretory pattern of growth hormone regulates liver carbonic anhydrase III. Studies in normal and mutant growth-hormone-deficient dwarf rats.
    Jeffery S; Carter ND; Clark RG; Robinson IC
    Biochem J; 1990 Feb; 266(1):69-74. PubMed ID: 1968744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of growth hormone-releasing factor (1-44) on growth hormone release from human somatotrophinomas in vitro: interaction with somatostatin, dopamine, vasoactive intestinal peptide and cycloheximide.
    White MC; Daniels M; Kendall-Taylor P; Turner SJ; Mathias D; Teasdale G
    J Endocrinol; 1985 May; 105(2):269-76. PubMed ID: 2859345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y; Rivest RW; Eshkol A; Sizonenko PC; Aubert ML
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different effects of somatostatin on in vitro growth hormone release in two porcine breeds with different growth rates.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    J Neuroendocrinol; 1996 Dec; 8(12):891-900. PubMed ID: 8953466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual dimorphism of somatostatin and growth hormone-releasing factor signaling in the control of pulsatile growth hormone secretion in the rat.
    Painson JC; Tannenbaum GS
    Endocrinology; 1991 Jun; 128(6):2858-66. PubMed ID: 1674685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.